Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin Stimulation Test in Cushing's Syndrome
NCT06635629Phase 2Recruiting
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Dec 2024
- Primary completion
- Oct 2028
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of desmopressin in Cushing syndrome, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Dec 2024; status: recruiting.
02
Drugs
desmopressin
03
Conditions
Cushing syndrome
Beyond the preview
Go deeper on NCT06635629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06635629.